ABO-Rh Prenatal

0010014
copy
 

Copy Utility


emailprint
Example Reports
A Negative
A Positive

Ordering Recommendation

Determine the patient's blood type (ABO and Rh D) in prenatal patients only, to evaluate possible risk for hemolytic disease of the fetus and newborn (HDFN) and to evaluate if the patient is a candidate for Rh Immunoglobulin. 

Mnemonic

ABORH-PR

Methodology

Hemagglutination

Performed

Mon-Fri

Reported

1-3 days

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation
Collect

Lavender (K2EDTA) or Pink (K2EDTA).

Specimen Preparation

Transport 7 mL whole blood. (Min: 3 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions
Remarks
Stability

Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable

Reference Interval

ABO Typing: A, B, AB, O
Rh Typing: Rh positive/Rh negative

Interpretive Data



Compliance Category

FDA

Note

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
11/18/2019
X
X
N/A

CPT Codes

86900; 86901

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
0010016 ABORh Prenatal 882-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Blood Type, Prenatal
ABO-Rh Prenatal